SUPERGEN
Dead / Cancelled — Cancelled — Section 8 (as of 27 Feb 2015)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78197047
- Registration number
- 2865719
- Mark type
- Word mark
- Filed
- 20 Dec 2002
- Published for opposition
- 29 Jul 2003
- Registered
- 20 Jul 2004
- Attorney of record
- Harold J. Milstein
Goods and services
- Class 040 — Treatment of materials: custom manufacturer for others of pharmaceuticals for the treatment of human disease and diagnostics for the diagnosis of human disease
Owner
- ASTEX PHARMACEUTICALS, INC., DUBLIN, CA, US
- Supergen, Inc., Dublin, CA, US
- Supergen, Inc., Dublin, CA, US
- Supergen, Inc., Dublin, CA, US
Prior registrations
Prosecution history
- 27 Feb 2015 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 12 Oct 2011 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Jul 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Jun 2010 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 21 Jul 2010 — REVIEW OF CORRESPONDENCE COMPLETE
- 19 Jul 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Jun 2010 — TEAS SECTION 8 & 15 RECEIVED
- 06 Oct 2008 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2004 — REGISTERED-PRINCIPAL REGISTER
- 02 May 2004 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Apr 2004 — ASSIGNED TO EXAMINER
- 28 Apr 2004 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Apr 2004 — USE AMENDMENT FILED
- 21 Apr 2004 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2004 — SOU TEAS EXTENSION RECEIVED